Delivery Order SPE2DB22D3501-SPE2DB24FWG84
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,182.23 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.26 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,472.32 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,289.65 Delivery Order contract is for the provision of CAPLYTA 10.5 MG CAPSULE 30S, a medical product, with a completion date of November 29, 2024. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,145.85 firm-fixed price delivery order is for the supply of CAPLYTA 42 MG capsules. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.22, is a delivery order for the provision of CAPLYTA 21 MG CAPSULE 30S. The contract is a firm fixed-price agreement with an ultimate completion date of April 14, 2025. This contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,314.77 firm fixed-price delivery order contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has a period of performance through November 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,865.45 firm fixed price delivery order is for 4566796994 CAPLYTA 42 MG CAPSULE 30S, with a period of performance through December 27, 2024. This award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,910.25 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award is a delivery order with a firm fixed price of $1,069.34 awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CAPLYTA 21 MG CAPSULE 30S, with a period of performance through May 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...